Viamet Pharmaceuticals Secures $12,000,014 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b7706a63-03cb-4774-9eee-eeac00bc0557
Date
9/29/2016
Company Name
Viamet Pharmaceuticals
Mailing Address
4505 Emperor Blvd. Durham, NC 27703 USA
Company Description
Viamet Pharmaceuticals discovers and develops best-in-class inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, our Metallophile Technology.
Website
http://www.viamet.com
Transaction Type
Venture Equity
Transaction Amount
$12,000,014
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 12 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed